Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas

Journal of Comparative Pathology

Volumn 150, Issue 2-3, 2014, Pages 169-174

  Flores, A R ^a   Rema A ^a   Carvalho, F ^a   Faustino, A ^a   Dias Pereira, P ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Carcinoma; Cat; Claudin 2; Mammary

Indexed keywords

CLAUDIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BREAST CARCINOMA; CANCER GRADING; CAT; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; METASTASIS; NONHUMAN; PRIORITY JOURNAL;

FELIDAE;

CARCINOMA; CAT; CLAUDIN-2; MAMMARY;

ANIMALS; CARCINOMA; CAT DISEASES; CATS; CLAUDIN-2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM GRADING; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84895871549     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2013.09.004     Document Type: Article

References (31)

1. Brooks S., Lomax-Browne H., Carter T., Kinch C., Hall D. Molecular interactions in cancer cell metastasis. Acta Histochemica 2010, 112:3-25.
2. Dias Pereira P., Gärtner F. Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue. Veterinary Record 2003, 153:297-302.
3. Elston C., Ellis I. Assessment of histological grade. Rosen's Breast Pathology 1996, 365-382. Lippincott-Raven, Philadelphia. P.P. Rosen (Ed.).
4. Gerhard R., Ricardo S., Albergaria A., Gomes M., Silva A.R., et al. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas. Breast 2012, 21:354-360.
5. Jakab C., Halász J., Szász A., Batmunkh E., Kiss A., et al. Expression and localization of claudin-1,-2,-3,-4,-5,-7 and -10 proteins in the normal canine mammary gland. Acta Veterinaria Hungarica 2008, 56:341-352.
6. Jakab C., Halász J., Szász A., Kiss A., Schaff Z., et al. Expression of claudin-1,-2,-3,-4,-5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours. Journal of Comparative Pathology 2008, 139:238-245.
7. Kim T., Huh J., Lee S., Kang H., Kim G., et al. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 2008, 53:48-55.
8. Kominsky S., Argani P., Korz D., Evron E., Raman V., et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22:2021-2033.
9. Langley R., Fidler I. The seed and soil hypothesis revisited - the role of tumor-stroma interactions in metastasis to different organs. International Journal of Cancer 2011, 128:2527-2535.
10. Lu S., Singh K., Mangray S., Tavares R., Noble L., et al. Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype. Modern Pathology 2012, 187:1-11.
11. Martin T., Jiang W. Loss of tight junction barrier function and its role in cancer metastasis. Biochimica et Biophysica Acta 2009, 1788:872-891.
12. Martin T., Mason M., Jiang W. Tight junctions in cancer metastasis. Frontiers in Bioscience 2011, 16:898-936.
13. Misdorp W., Else R., Hellmén E., Lipscomb T. Histological Classification of Mammary Tumours of the Dog and Cat 1999, 1-59. Armed Forces Institute of Pathology, Washington DC. 2nd Edit.
14. Misdorp W., Romijn A., Hart A. Feline mammary tumors: a case-control study of hormonal factors. Anticancer Research 1991, 11:1793-1797.
15. Morin P. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Research 2005, 65:9603-9606.
16. Ouban A., Ahmed A. Claudins in human cancer: a review. Histology and Histopathology 2010, 25:83-90.
17. Park D., Kåresen R., Axcrona U., Noren T., Sauer T. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. Acta Pathologica Microbiologica et Immunologica Scandinavica 2007, 115:52-65.
18. Peñafiel-Verdu C., Buendia A., Navarro J., Ramirez G., Vilafranca M., et al. Reduced expression of E-cadherin and β-catenin and high expression of basal cytokeratins in feline mammary carcinomas with regional metastasis. Veterinary Pathology 2012, 49:979-987.
19. Perou C. Molecular stratification of triple-negative breast cancers. Oncologist 2011, 16(Suppl. 1):61-70.
20. Prat A., Parker J., Karginova O., Fan C., Livasy C., et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Research 2010, 12:R68.
21. Sauer T., Pedersen M., Ebeltoft K., Naess O. Reduced expression of claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 2005, 16:193-198.
22. Soini Y. Claudins 2, 3, 4 and 5 in Paget's disease and breast carcinoma. Human Pathology 2004, 35:1531-1536.
23. Soini Y. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 2005, 46:551-560.
24. Szász M. Claudins as prognostic factors of breast cancer. Magyar Onkologia 2012, 56:209-212.
25. Szasz A., Tokés A., Micsinai M., Krenacs T., Jakab C., et al. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis. Clinical and Experimental Metastasis 2011, 28:55-63.
26. Tabariès S., Dong Z., Annis M., Omeroglu A., Pepin F., et al. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene 2011, 30:1318-1328.
27. Tabariès S., Dupuy F., Dong Z., Monast A., Annis M., et al. Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes. Molecular and Cellular Biology 2012, 32:2979-2991.
28. Takehara M., Nishimura T., Mima S., Hoshino T., Mizushima T. Effect of claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biological and Pharmaceutical Bulletin 2009, 32:825-831.
29. Telgenhoff D., Ramsay S., Hilz S., Slusarewicz P., Shroot B. Claudin 2 mRNA and protein are present in human keratinocytes and may be regulated by all-trans-retinoic acid. Skin Pharmacology and Physiology 2008, 21:211-217.
30. Tokés A., Kulka J., Paku S., Szik A., Páska C., et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Research 2005, 7:296-305.
31. Zappulli V., De Cecco S., Trez D., Caliari D., Aresu L., et al. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours. Journal of Comparative Pathology 2012, 147:161-170.